Heroin and its metabolites: relevance to heroin use disorder

MS Milella, G D'Ottavio, S De Pirro, M Barra… - Translational …, 2023 - nature.com
Heroin is an opioid agonist commonly abused for its rewarding effects. Since its synthesis at
the end of the nineteenth century, its popularity as a recreational drug has ebbed and …

The value of harm reduction for injection drug use: A clinical and public health ethics analysis

L Vearrier - Disease-a-Month, 2019 - Elsevier
The US is facing dual public health crises related to opioid overdose deaths and HIV.
Injection drug use is fueling both of these epidemics. The War on Drugs has failed to stem …

Goofballing of opioid and methamphetamine: The science behind the deadly cocktail

HM Hazani, I Naina Mohamed, M Muzaimi… - Frontiers in …, 2022 - frontiersin.org
Globally, millions of people suffer from various substance use disorders (SUD), including
mono-and polydrug use of opioids and methamphetamine. Brain regions such as the …

The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the …

DK van Santen, A Boyd, A Matser, L Maher… - …, 2021 - Wiley Online Library
Background and aims Major declines in HIV and hepatitis C and B virus (HCV/HBV)
incidence among people who inject drugs (PWID) have been attributed to early …

Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different …

DK van Santen, S Lodi, P Dietze, W Van Den Boom… - …, 2023 - Wiley Online Library
Abstract Background and Aims Although the Netherlands, Canada and Australia were early
adopters of harm reduction for people who inject drugs (PWID), their respective HIV and …

New developments in managing opioid addiction: impact of a subdermal buprenorphine implant

ML Itzoe, M Guarnieri - Drug design, development and therapy, 2017 - Taylor & Francis
Opioid addiction to prescription and illicit drugs is a serious and growing problem. In the US
alone,> 2.4 million people suffer from opioid use disorder. Government and pharmaceutical …

[HTML][HTML] Personality disorders, addictions and psychopathy as predictors of criminal behaviour in a prison sample

G Flórez, V Ferrer, LS García, MR Crespo… - Revista espanola de …, 2019 - ncbi.nlm.nih.gov
Aims Disturbances in personality and addictions are associated with an increased risk of
committing crimes and therefore of being imprisoned. In this study, the relationship between …

Quantifying stigma effects: The influence of stigma and pharmacist implicit attitudes on opioid agonist treatment consumer well-being.

T Caruana - Stigma and Health, 2024 - psycnet.apa.org
Opioid agonist treatment (OAT) is subject to stigma due to its association with criminalized
and socially discredited illicit drug use behaviors. This study aimed to explore if the negative …

Attitudes toward methadone treatment among Black/African Americans: Implications for engagement and retention.

KK Rigg, R Weaver, E Kusiak - American Journal of …, 2023 - psycnet.apa.org
Despite its ability to lower the risk of opioid misuse, methadone is viewed by patients with a
certain degree of ambivalence. Research has documented a variety of patient attitudes …

County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019

B Corry, N Underwood, LJ Cremer… - Drug and Alcohol …, 2022 - Elsevier
Background Differences in availability of medications for opioid use disorder (MOUD)
buprenorphine and methadone exist. Factors that may influence such differences in …